Clinical trial · Interventional
Molecular Breast Imaging in Screening Breast Cancer
NCT03082456CI-TRIAL-00045084completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The molecular breast imaging (MBI) is a potential modality to screen breast cancer. In this study, we compare and evaluate the recall rate/diagnostic efficiency of MBI, mammography and breast sonography, and aim to determine best ways of breast cancer screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breast ultrasound | Diagnostic Test | — | UNRESOLVED |
| Mammography | Diagnostic Test | — | UNRESOLVED |
| Molecular breast imaging | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Three breast screening modalities
- description
- Subjects who have had mammography less than two years ago will receive MBI and breast ultrasound only. Other participants will receive three interventions including molecular breast imaging, mammography and breast ultrasound. The interval between each examination will be less than 6 months.
- interventionNames
- Diagnostic Test: Molecular breast imaging
- Diagnostic Test: Mammography
- Diagnostic Test: Breast ultrasound
Primary outcomes (1)
- measure
- Recall rate
- timeFrame
- 6 months
- description
- The frequency with which a radiologist or physician interprets findings of an examination as positive
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients undergoing myocardial perfusion imaging will be eligible if they sign the informed consent. Exclusion Criteria: * They are unable to understand and sign the consent form * They are physically unable to sit upright and still for 20 minutes. * They have undergone breast surgery or breast biopsy within the last 12 months. * They have had trauma to the breast tissue or undergone radiation treatment to the breast within the last 12 months.
References
Publications (0)
Data not yet available
No reference posted for this study.